BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Marc Walther, President and CEO of Impact Fusion Files a Patent Pending Related to Artificial Insemination of Mammals

  October 15, 2025

   · 

  10 min read
• Press Releases

  insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform

  October 15, 2025

   · 

  4 min read
• Press Releases

  EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

  October 15, 2025

   · 

  13 min read
• Press Releases

  Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 15, 2025

   · 

  4 min read
• Press Releases

  Inventiva Announces the Implementation of a New ATM Program

  October 15, 2025

   · 

  8 min read
• Press Releases

  Privo Technologies Completes Phase 2 Run-In in PRV111 Oral Cancer Trial, Highlighting Potential to Spare Patients from Surgery

  October 15, 2025

   · 

  4 min read
• Press Releases

  Olympus Canada Inc. Announces Launch of Advanced Imaging Endoscopes as Part of the EVIS X1™ Endoscopy System

  October 15, 2025

   · 

  4 min read
• Press Releases

  Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

  October 15, 2025

   · 

  1 min read
• Press Releases

  Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

  October 15, 2025

   · 

  1 min read
• Press Releases

  Synnovation to Present SNV1521 (PARP1) Phase 1 Study Results at the European Medical Oncology (ESMO) Congress 2025 and Announces Clinical Collaboration with DualityBio to Evaluate the Combination of SNV1521 with Duality’s HER3 ADC, DB-1310

  October 15, 2025

   · 

  3 min read